A Follow-up Study to Assess Long-term Immunogenicity and Safety of NicVAX/Placebo as an Aid to Smoking Cessation

Clinical trial NCT01304810 · COMPLETED

Trial details

NCT number: NCT01304810
Sponsor: Nabi Biopharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Smoking Cessation Nicotine Dependence

Start date: 2011-01-01
Primary completion: 2011-08-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.